Acute Kidney Injury to Chronic Kidney Disease Transition

Contributions to Nephrology

Volumn 193, Issue , 2018, Pages 45-54

  Fiorentino, Marco ^a,c   Grandaliano, Giuseppe ^b   Gesualdo, Loreto ^a   Castellano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; CELL AGING; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE EXACERBATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; KIDNEY TUBULE; NEPHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ACUTE KIDNEY INJURY; CELLULAR SENESCENCE; DISEASE PROGRESSION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HUMANS; KIDNEY TUBULES; NEPHRITIS; PERICYTES; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 85051975343     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000484962     Document Type: Article

References (37)

1. Singbartl K, Kellum JA: AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81: 819-825.
2. Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81: 442-448.
3. Goldstein SL, Chawla L, Ronco C, Kellum JA: Renal recovery. Crit Care 2014; 18: 301.
4. Chawla LS, Kimmel PL: Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012; 82: 516-524.
5. Heung M, Steffick DE, Zivin K, et al: Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am J Kidney Dis 2016; 67: 742-752.
6. Basile DP, Bonventre JV, Mehta R, et al: Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol 2016; 27: 687-697.
7. Chou YH, Huang TM, Chu TS: Novel insights into acute kidney injury-chronic kidney disease continuum and the role of reninangiotensin system. J Formos Med Assoc 2017; 116: 652-659.
8. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J clin invest 2002; 110: 341-350.
9. Humphreys BD, Lin SL, Kobayashi A, et al: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
10. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543.
11. Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK: Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 2015; 26: 1765-1776.
12. Tanaka S, Tanaka T, Nangaku M: Hypoxia as a key player in the AKI-to-CKD transition. Am J Physiol Renal Physiol 2014; 307:F1187-F1195.
13. Basile DP, Friedrich JL, Spahic J, et al: Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal physiol 2011; 300:F721-F733.
14. Castellano G, Stasi A, Intini A, et al: Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein. Crit care 2014; 18: 520.
15. Curci C, Castellano G, Stasi A, et al: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant 2014; 29: 799-808.
16. Ko GJ, Grigoryev DN, Linfert D, et al: Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 2010; 298:F1472-F1483.
17. Lee S, Huen S, Nishio H, et al: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317-326.
18. Zhou D, Tan RJ, Fu H, Liu Y: Wnt/?-catenin signaling in kidney injury and repair: a double-edged sword. Lab Invest 2016; 96: 156-167.
19. Sato Y, Mii A, Hamazaki Y, et al: Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. JCI insight 2016; 1:e87680.
20. Bhargava P, Schnellmann RG: Mitochondrial energetics in the kidney. Nat Rev Nephrol 2017; 13: 629-646.
21. Funk JA, Schnellmann RG: Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 2012; 302:F853-F864.
22. Gomez H, Kellum JA, Ronco C: Metabolic reprogramming and tolerance during sepsisinduced AKI. Nat rev Nephrol 2017; 13: 143-151.
23. Hasegawa K, Wakino S, Yoshioka K, et al: Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem 2010; 285: 13045-13056.
24. Rodriguez-Romo R, Berman N, Gomez A, Bobadilla NA: Epigenetic regulation in the acute kidney injury (AKI) to chronic kidney disease transition (CKD). Nephrology (Carlton) 2015, Epub ahead of print.
25. Cao W, Jin L, Zhou Z, et al: Overexpression of intrarenal renin-angiotensin system in human acute tubular necrosis. Kidney Blood Press Res 2016; 41: 746-756.
26. Alge JL, Karakala N, Neely BA, Janech MG, Velez JC, Arthur JM: Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit. Crit care 2013; 17:R69.
27. Rodriguez-Romo R, Benitez K, Barrera-Chimal J, et al: AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease. Kidney Int 2016; 89: 363-373.
28. Chou YH, Huang TM, Pan SY, et al: Reninangiotensin system inhibitor is associated with lower risk of ensuing chronic kidney disease after functional recovery from acute kidney injury. Sci Rep 2017; 7: 46518.
29. Yang X, Chen C, Tian J, et al: Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: a prospective, two-stage study. J Am Soc Nephrol 2015; 26: 2032-2041.
30. Ferenbach DA, Bonventre JV: Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat rev Nephrol 2015; 11: 264-276.
31. Hu MC, Shi M, Zhang J, et al: Renal production, uptake, and handling of circulating ?Klotho. J Am Soc Nephrol 2016; 27: 79-90.
32. Castellano G, Intini A, Stasi A, et al: Complement modulation of anti-aging factor klotho in ischemia/reperfusion injury and delayed graft function. Am J Transplant 2016; 16: 325-333.
33. Izquierdo MC, Perez-Gomez MV, Sanchez-Nino MD, et al: Klotho, phosphate and inflammation/ ageing in chronic kidney disease. Nephrol Dial Transplant 2012; 27 Suppl 4:iv6-iv10.
34. Kobayashi T, Terada Y, Kuwana H, et al: Expression and function of the Delta-1/ Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250.
35. Sorensen-Zender I, Rong S, Susnik N, et al: Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. Am J Physiol Renal Physiol 2014; 306:F907-F915.
36. Tan HL, Yap JQ, Qian Q: Acute kidney injury: tubular markers and risk for chronic kidney disease and end-stage kidney failure. Blood Purif 2016; 41: 144-150.
37. Zhou X, Zang X, Ponnusamy M, et al: Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression. J Am Soc Nephrol 2016; 27: 2092-2108.